Ivermectin effect in the treatment of patients with covid-19
Phase 3
Recruiting
- Conditions
- Covid-19.COVID-19 diseaseU07.02
- Registration Number
- IRCT20190602043787N3
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Covid-19 patients whose diagnosis is confirmed by clinical signs of patients and other laboratory parameters,are checked:physicians clinical diagnosis includes the patients general condition and clinical symptoms.
O2 saturation less than 93% in infected patients
laboratory parameters(ESR,CRP,Ferrittin,CBC,Lymph count,D-dimer(if present))
Positive Real time PCR test result for Covid-19
Patients in the age range of 16-75 years
Exclusion Criteria
Pregnancy and breastfeeding
Concomitant use of warfarin
Patients over 75 years old
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of hospital stay. Timepoint: Death rate up to 30 days from the time of entry into the trial. Method of measurement: Review files.;Illness severity. Timepoint: Daily. Method of measurement: By the physician clinical diagnosis ctiteria includ the patients general condition and clinical symptoms and improvement of laboratory parameters(ESR,CRP,Ferrittin,CBC,Lymph count,D-dimer(if available)) and improvement O2 saturation.
- Secondary Outcome Measures
Name Time Method eed to mecanical ventilation. Timepoint: Daily. Method of measurement: The patients general condition and clinical symptoms and O2 saturation.